← Back to Search

eMBC for Postpartum Depression and Anxiety (eMBC Trial)

N/A

Waitlist Available

Led By Renu Gupta, MD

Research Sponsored by Women's College Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥18

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4, 8, and 12 weeks post randomization

Awards & highlights

eMBC Trial Summary

This trial is testing whether it's feasible to use a model of care called measurement based care (MBC) to treat perinatal depression and anxiety. In MBC, patients' psychiatric symptoms are routinely tracked and reviewed together by a patient and their doctor to better manage symptoms. The trial will use electronic MBC (eMBC), where patients can enter their symptoms into their electronic medical records before their appointment. The study will evaluate the feasibility of recruitment and retention for a future efficacy trial, and acceptability and adherence to a trial protocol.

Who is the study for?

This trial is for individuals aged 18 or older who are currently pregnant or have a child under one year old, experiencing depression and anxiety. They must be able to consent, read, and speak English. It's not suitable for those with active suicidal thoughts, substance abuse issues, past/current mania or psychosis.Check my eligibility

What is being tested?

The eMBC Intervention is being tested to manage symptoms of perinatal depression and anxiety. Patients will track their psychiatric symptoms electronically before appointments for review with their doctor. The study aims to test the feasibility of this approach.See study design

What are the potential side effects?

Since this trial involves tracking symptoms rather than medication or invasive procedures, direct side effects from interventions aren't expected; however, discussing mental health may cause emotional discomfort.

eMBC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

eMBC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Feasibility of the trial protocol: Adherence

Feasibility of the trial protocol: Participant Acceptability

Feasibility of the trial protocol: Provider Acceptability

+1 more

Secondary outcome measures

Clinical outcomes - antidepressant side effects

Clinical outcomes - anxiety symptoms

Clinical outcomes - clinician-assessed depression symptoms

+3 more

Other outcome measures

Co-variates: Participants

Co-variates: Providers

eMBC Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: eMBC InterventionExperimental Treatment1 Intervention

Participants in the intervention arm are followed by their RLS psychiatrists during the study at clinically appropriate intervals with the addition of eMBC.

Group II: Care As UsualActive Control1 Intervention

Participants in the control condition are followed by their RLS psychiatrists during the study as per usual care.

0 / 1Eligibility criteria met